High-dose oxytocin protocol reduces postpartum hemorrhage

A study led by Michigan Medicine suggests that increasing the dose of oxytocin administered after childbirth can significantly reduce postpartum hemorrhage. The research, published in Obstetrics & Gynecology, The Green Journal, evaluated a quality improvement initiative at University of Michigan Health Von Voigtlander Women's Hospital.

The initiative involved increasing the oxytocin dose administered during the first hour after birth from 30 units to 60 units. Following the implementation of this higher-dose protocol, which included updated medication orders and staff training, researchers observed a meaningful reduction in hemorrhage rates. The most significant impact was seen in vaginal births, which experienced a relative reduction in hemorrhage of approximately 40%.

Postpartum hemorrhage remains a leading cause of maternal illness and death. Lead author Jourdan Triebwasser, M.D., M.A., noted that the findings suggest a simple change to administration protocols can strengthen the prevention and management of obstetric complications.